[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350785-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-350785-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","prevalence-and-factors-associated-with-chemotherapy-induced-peripheral-neuropathy-among-adult-patients-with-cancer-at-mbarara-regional-cancer-centre-a-crosssectional-study","Prevalence and factors associated with chemotherapy induced peripheral neuropathy among adult patients with cancer at Mbarara Regional Cancer Centre - a crosssectional study","","Chemotherapy is a widely used cancer treatment, yet several agents can damage peripheral sensory, motor, and autonomic neurons, producing chemotherapy induced peripheral neuropathy (CIPN). CIPN is a frequent adverse drug reaction, especially with platinum analogs, vinca alkaloids, and taxanes, and severe cases may lead to profound impairment. This cross-sectional study evaluated CIPN prevalence, associated factors, and management among adults receiving chemotherapy at Mbarara Regional Cancer Centre.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prevalence-and-factors-associated-with-chemotherapy-induced-peripheral-neuropathy-among-adult-patients-with-cancer-at-mbarara-regional-cancer-centre-a-crosssectional-study/350785/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prevalence-and-factors-associated-with-chemotherapy-induced-peripheral-neuropathy-among-adult-patients-with-cancer-at-mbarara-regional-cancer-centre-a-crosssectional-study/350785.png","ImageObject",300,407,{"name":42,"@type":43},"CatatanPagi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is chemotherapy induced peripheral neuropathy (CIPN)?","Question",{"text":63,"@type":64},"CIPN is a disorder affecting peripheral sensory, motor, and autonomic neurons triggered by the toxic effects of chemotherapy drugs, and it is commonly seen with platinum analogs, vinca alkaloids, and taxanes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What was the prevalence of CIPN in this study?",{"text":68,"@type":64},"The study reported a CIPN prevalence of 31.1% among adult cancer patients receiving chemotherapy at Mbarara Regional Cancer Centre.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were associated with the occurrence of CIPN?",{"text":72,"@type":64},"Factors included age ≥60 years, concurrent administration of non-chemotherapeutic neurotoxic drugs, and past resolved neuropathy prior to starting chemotherapy.",{"name":74,"@type":61,"acceptedAnswer":75},"How was CIPN treated for patients who received management?",{"text":76,"@type":64},"About 30.1% of patients with CIPN received treatment, managed with agents such as pregabalin, gabapentin, amitriptyline, vitamin B complex, and other listed medications.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},350785,1790707200,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":143,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":12,"update_tm":147,"read_time":148,"preview_page_count":33,"preview_urls":149},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Avaga etal. BMC Neurology (2026) 26:564 BMC Neurology  \n[https://doi.org/10.1186/s12883-026-05078-y](https://doi.org/10.1186/s12883-026-05078-y)  \nRESEARCH Open Access  \nPrevalence and factors associated    \nwith chemotherapy induced peripheral neuropathy among adult patients with cancer at Mbarara Regional Cancer Centre: a crosssectional study  \nStanslas Avaga1*, Simon Ndrusini Ngbape 1, Abdu Damale 1, Idrine Kalinge Kato2, Laura Bacia 1, Caroline Nakate1, Julius Kyomya1, John Isiiko1,2, Robert Tamukong1 and Tadele MekuriyaYadesa1,3  \nAbstract  \nBackground Chemotherapy is a common modality used for management of cancers but some agents are known to cause peripheral neuropathy. Chemotherapy induced peripheral neuropathy (CIPN) refers to a disorder in structure and functionality of peripheral sensory, motor, and autonomic neurons triggered by the toxic effects of these drugs. CIPN is a common adverse drug reaction (ADR) caused by mainly platinum analogs, vinca alkaloids and taxanes. Severe CIPN can cause paresis, complete immobilization and disability. The objectives ofthis study were to determine the prevalence, factors associated with and evaluate treatment of CIPN among adult patients with cancer at Mbarara Regional Cancer Centre.  \nMethods A cross-sectional study was conducted for a period of 2 months among adult patients with cancer receiving chemotherapy at Mbarara Regional Cancer Centre. Consecutive sampling technique was used to enroll 235 participants into the study. Data collection was done through patient interviews and file reviews. Assessment of the clinical features of CIPN was done using EORTC-QLQ-CIPN20 tool. SPSS version 27 was used for data entry and analysis.  \nResults The prevalence of CIPN was 31. 1% . The factors associated with occurrence of CIPN include age greater or equal to 60 years (aOR = 2 . 04, 95% CI: 1.07–3. 91, p-value = 0 . 031), concurrent administration of non-chemotherapeutic neurotoxic drugs (aOR = 6 . 50, 95% CI: 1.64–9. 36), past resolved neuropathy prior to initiation of chemotherapy  \n(aOR = 6 . 99, 95% CI: 2 .28–9. 21) . 30. 1% of patients with CIPN received treatment and were managed with agents such as pregabalin, gabapentin, cachnerve, Nat B, neuroton, amitriptyline and vitamin B complex. The American Society of Clinical Oncology guideline recommends use of duloxetine for treatment of CIPN.  \n*Correspondence:  \nStanslas Avaga [avagastanslas020@gmail.com](avagastanslas020@gmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nAvaga et al. BMC Neurology (2026) 26:564 Page 2 of 10  \nConclusion Nearly one-third of patients at Mbarara Regional Cancer Centre had CIPN. Patient age 60 years and above, past resolved neuropathy and concurrent administration of non-chemotherapeutic neurotoxic drugs are factors associated with occurrence of","cbCaif0W6ItOECgl","https://ap.wps.com/l/cbCaif0W6ItOECgl","pdf",1642369,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What is chemotherapy induced peripheral neuropathy (CIPN)?\",\"answer\":\"CIPN is a disorder affecting peripheral sensory, motor, and autonomic neurons triggered by the toxic effects of chemotherapy drugs, and it is commonly seen with platinum analogs, vinca alkaloids, and taxanes.\"},{\"question\":\"What was the prevalence of CIPN in this study?\",\"answer\":\"The study reported a CIPN prevalence of 31.1% among adult cancer patients receiving chemotherapy at Mbarara Regional Cancer Centre.\"},{\"question\":\"Which factors were associated with the occurrence of CIPN?\",\"answer\":\"Factors included age ≥60 years, concurrent administration of non-chemotherapeutic neurotoxic drugs, and past resolved neuropathy prior to starting chemotherapy.\"},{\"question\":\"How was CIPN treated for patients who received management?\",\"answer\":\"About 30.1% of patients with CIPN received treatment, managed with agents such as pregabalin, gabapentin, amitriptyline, vitamin B complex, and other listed medications.\"}]","Prevalence and factors associated with chemotherapy induced peripheral neuropathy among adult patients with cancer at Mbarara Regional Cancer Centre - a crosssectional study | PDF",1790091081,25,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af2bc207d1e6b930e0ca9d59fddacaa2.webp",983,1310,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68b0008b87b6393322dd29721795485c.webp",982,1309,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a38a2118764f99d98e68649de97f9c25.webp",981,1308,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05f98d970fb2030087f708ebb08298ac.webp",980,1306]